Sevim, A. Et Al. 2025. Dubermatinib may enhance the anti-cancer efficacy of gemcitabine on Panc-1 cells. X. Multidisciplinary Cancer Research Congress , (Eskişehir, Turkey), 208.

Sevim, A., Atıcı, Y., Altunok, T. H., Sarioğlu Bozkurt, A., Sönmez, Ö., & Bayram, E., (2025). Dubermatinib may enhance the anti-cancer efficacy of gemcitabine on Panc-1 cells . X. Multidisciplinary Cancer Research Congress (pp.208). Eskişehir, Turkey

Sevim, Ahsenur Et Al. "Dubermatinib may enhance the anti-cancer efficacy of gemcitabine on Panc-1 cells," X. Multidisciplinary Cancer Research Congress, Eskişehir, Turkey, 2025

Sevim, Ahsenur Et Al. "Dubermatinib may enhance the anti-cancer efficacy of gemcitabine on Panc-1 cells." X. Multidisciplinary Cancer Research Congress , Eskişehir, Turkey, pp.208, 2025

Sevim, A. Et Al. (2025) . "Dubermatinib may enhance the anti-cancer efficacy of gemcitabine on Panc-1 cells." X. Multidisciplinary Cancer Research Congress , Eskişehir, Turkey, p.208.

@conferencepaper{conferencepaper, author={Ahsenur Sevim Et Al. }, title={Dubermatinib may enhance the anti-cancer efficacy of gemcitabine on Panc-1 cells}, congress name={X. Multidisciplinary Cancer Research Congress}, city={Eskişehir}, country={Turkey}, year={2025}, pages={208} }